alpha-glucosidase inhibitor


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.
Related to alpha-glucosidase inhibitor: thiazolidinedione

α-glucosidase inhibitor

an oral agent that aids in the control of diabetes mellitus by delaying the absorption of glucose from the digestive system.

alpha-glucosidase inhibitor

An oral drug that lowers blood sugars by preventing carbohydrate absorption from the gastrointestinal tract.
See also: inhibitor

α-glu·co·si·dase in·hib·i·tor

(glū-kō'si-dās in-hib'i-tŏr)
Oral agent that aids control of diabetes mellitus by delaying absorption of glucose from digestive system.
References in periodicals archive ?
Alpha-glucosidase inhibitors in diabetes: Efficacy in NIDDM subjects.
* Alpha-glucosidase inhibitors (AL-fa gloo-KOS-ih-dayss in-HIB-it-ers).
Keywords: Alpha-glucosidase inhibitors, DPP4 inhibitors, GLP1 receptor agonists, Metformin, Pioglitazone, Pramlintide, SGLT2 inhibitors.
Both dipeptidyl peptidase-4 (DPP-4) inhibitors and alpha-glucosidase inhibitors (AGIs) appear to be weight-neutral or to induce minimal changes in weight.
Available oral agents include insulinotropic agents (sulfonylureas and meglitinides), biguanides, alpha-glucosidase inhibitors, and thiazolidinediones (glitazones).
According to the National Diabetes Information Clearinghouse (a federal agency), five major classes of diabetes drugs are on the market: sulfonylureas, biguanides, alpha-glucosidase inhibitors, thiazolidinediones and meglitinides.
* Acknowledgments Find Your Diabetes Medicines(*) Sulfonylureas Amaryl DiaBeta Diabinese Dymelor Glucotrol Glucotrol XL Glynase PresTab Micronase Orinase Tolinase Biguanides Glucophage Alpha-glucosidase Inhibitors Glyset Precose Thiazolidinediones Rezulin Meglitinides: Prandin Insulins Lispro (Humalog) Regular Premixed Ultralente NPH or Lente
According to the metabolic fulcrum-based, strategy, insulin and insulin secretagogues are preferred in patients with predominant insulin deficiency (catabolism), dipeptidyl peptidase 4 inhibitors (DPP4i) and alpha-glucosidase inhibitors (AGIs) find utility in eubolic type 2 diabetes, while glucagon- like peptide 1 receptor agonists (GLP1RA) and sodium glucose cotransporter 2 inhibitors (SGLT2i) are strongly indicated in those with predominant insulin resistance (maladaptive anabolism).
Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.
* Alpha-glucosidase inhibitors. First-trimester experience with acarbose (Precose) and miglitol (Glyset), which lower postprandial hyperglycemia by delaying glucose absorption, is very limited, so they are not recommended for the treatment of type 2 diabetes in pregnancy or GDM.
* Alpha-glucosidase inhibitors. Firsttrimester experience with acarbose (Precose) and miglitol (Glyset), which lower postprandial hyperglycemia by delaying glucose absorption, is very limited, so they are not recommended for the treatment of type 2 diabetes in pregnancy or GDM.